Table 1.
Baseline characteristics of study participants
| Mean (95% CI) |
|||
|---|---|---|---|
| Variable | artemether/lumefantrine arm | artemether/lumefantrineplus lopinavir/ritonavir arm | P value |
| Age (years) | 34.5 (29.9–39.0) | 37.6 (34.3–40.9) | 0.2 |
| Body weight (kg) | 63.8 (58.1–69.5) | 64.0 (57.6–70.5) | 0.9 |
| Height (cm) | 160.1 (155.2–165.0) | 165.8 (161.5–170.0) | 0.06 |
| Body mass index (kg/m2) | 25.1 (22.2–28.0) | 23.4 (21.0–25.8) | 0.3 |
| Haemoglobin (mg/dL) | 12.6 (11.4–13.8) | 14.3 (13.8–14.9) | 0.004a |
| QTc (ms) | 411.5 (402.3–420.6) | 416.8 (406.0–427.5) | 0.4 |
aStatistically significant.